Aclarion (ACON) announced that its board of directors has authorized a share repurchase program of up to $2.5M of the company’s outstanding common stock. Aclarion expects to execute the repurchase program over the next 12 months. The company intends to fund the repurchase program using existing cash and cash equivalents.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACON:
- Aclarion granted U.S. patent for AI-driven back pain assessment
- Aclarion announces commercial agreement with Weill Cornell Medicine
- Echo Lake calls on Aclarion director David Neal to resign
- Aclarion Adopts One-Year Stockholder Rights Protection Plan
- Aclarion adopts limited duration stockholder rights plan